A fannin kiwon lafiya na rigakafi, an daɗe ana bikin folic acid (bitamin B9) saboda muhimmiyar rawar da yake takawa, musamman a lafiyar uwa da jariri. Duk da haka, ci gaban da aka samu kwanan nan da kuma manyan bincike daga Janairu 2026, suna sake fasalin fahimtar al'ummar likitoci game da yadda da lokacin da za a gwada wannan muhimmin sinadari. Labarin ya nuna babban sauyi daga gwajin ƙwayoyin jinin ja (RBC) na yau da kullun zuwa hanyoyin magani mafi inganci, yayin da a lokaci guda kuma ke bayyana wani sabon yanki na musamman a gwajin ganewar asali.

Canjawa daga Gwajin RBC Folate

Shekaru da dama, gwajin folate na RBC an ɗauke shi a matsayin kayan aiki na yau da kullun don auna adadin folate na dogon lokaci a cikin jiki. Duk da haka, manyan jagororin likita yanzu suna ƙaura daga wannan aikin. Wani sabon jagorar asibiti daga Anthem, wanda aka buga a ranar 6 ga Janairu, 2026, ya bayyana a sarari cewa **gwajin folic acid na RBC "ba lallai bane a fannin lafiya a kowane hali"**. Jagorar ta jaddada cewa gwajin folate na jini ya fito a matsayin kimantawa mafi inganci, abin dogaro, kuma daidaitacce na matsayin folate na yanzu.

Dalilin da ya sa wannan sauyi ya samo asali ne daga ingancin asibiti da kuma nasarar lafiyar jama'a. Tun lokacin da aka tilasta wa kayayyakin hatsi da folic acid a Amurka a shekarar 1998, ƙarancin folate mai yawa a asibiti ya zama "abin da ba kasafai ake samu ba," tare da raguwar ƙarancin daga 18.3% zuwa ƙasa da 0.2%. Bugu da ƙari, shaidu sun nuna cewa gwaje-gwajen folate na RBC suna fama da ƙarancin hanyoyin aiki, gami da rashin daidaito, bambancin fasaha, da kuma sauƙin kamuwa da kurakurai a cikin shirya samfurin. Nazari da yawa sun tabbatar da cewa matakan folate na RBC ba su ba da ƙarin bayani mai mahimmanci fiye da wanda aka bayar ta hanyar gwajin folate mai sauƙi a cikin jini, wanda hakan ya sa na farko ya zama zaɓi mai rikitarwa kuma mara inganci a cikin aikin likitanci na zamani.

Wannan yanayin duniya na gaske ya tabbata ne ta hanyar wani babban bincike da aka yi a baya-bayan nan daga Jami'ar Uppsala da ke Sweden, wanda aka buga a *Biomedicines* a ranar 9 ga Janairu, 2026. Binciken sama da ma'aunin folate 578,000 daga 2005 zuwa 2024, ya gano cewa yayin da matakan folate na plasma suka ƙaru a cikin shekaru ashirin, sauyawa tsakanin dandamali daban-daban na nazari na iya haifar da sauye-sauye a cikin hanyoyin aiki. Wannan yana nuna mahimmancin ci gaba da sa ido kan masu amfani da biomarkers don gano sauye-sauyen nazari da kuma sa ido kan yanayin abinci mai gina jiki na dogon lokaci, yana ƙara tallafawa buƙatar ingantattun hanyoyin gwaji.

Muhimmancin Folate Mai Dorewa a Ciki

Duk da juyin halittar hanyoyin gwaji, har yanzu ba a yi jayayya kan mahimmancin folate ba, musamman a lokacin daukar ciki. Wani bincike da aka buga a *Tzu Chi Medical Journal* a ranar 21 ga Janairu, 2026, ya kara karfafa mummunan sakamakon karancin folate a lokacin daukar ciki. Binciken, wanda ya lura da mahalarta 351, ya gano cewa **masu juna biyu da ke da karancin folic acid suna da babban haɗarin samun mummunan sakamako**, gami da haihuwa kafin lokacin haihuwa (16.94% a cikin rukunin masu karamin karfi) da kuma takaita girman tayi (27.11% a cikin rukunin masu karamin karfi idan aka kwatanta da 13.38% a cikin rukunin masu babban karfi). Masu binciken sun kammala da cewa bin shawarwarin abinci mai gina jiki don karin folic acid yana da mahimmanci don hana wadannan matsaloli.

Wannan shaidar asibiti tana goyon bayan ci gaba da shirye-shiryen kiwon lafiyar jama'a. Misali, shirye-shiryen kiwon lafiya na gida, kamar kunshin sabis na "Xiang series" a Changsha, China, suna haɗa ƙarin folic acid da jagora cikin cikakkun hanyoyin kulawa na "kafin daukar ciki zuwa bayan haihuwa", suna nuna jajircewar duniya ga wannan muhimmin matakin rigakafi.

Sabon Babba: Gwajin Ganewa don Sha Folate

Wataƙila labari mafi ban mamaki a watan Janairun 2026 shine matakin gano ba kawai matakan folate ba, har ma da ikon jiki na amfani da folate da yake samu. A ranar 12 ga Janairu, Micoy Therapeutics ta sanar da cewa Hukumar Abinci da Magunguna ta Amurka (FDA) ta ba da izinin Gwajin NeuroLume™ nata na Na'urar Breakthrough. Wannan sabon gwajin kulawa yana gano kasancewar ƙwayoyin rigakafi na folate receptor alpha (FRAAs), waɗanda zasu iya toshe jigilar folate zuwa kyallen takarda.

Wannan yana wakiltar canjin tsari. Gwaje-gwajen jini ko na plasma na yau da kullun suna auna adadin folate da ke cikin jini, amma ba za su iya bayyana dalilin da yasa mutum zai iya samun ƙarancin folate mai aiki ba duk da isasshen abinci ko ƙarin abinci. An tsara Gwajin NeuroLume don amfani ga manya da yara marasa lafiya da ke fuskantar kimantawa don rashin folate mara bayani, anemia mai yawa, ko matsalolin ci gaba inda ake zargin rashin lafiyar folate. Wannan ci gaban, wanda aka tallafa masa shekaru da yawa na bincike, ya yi alƙawarin samar da bayanai na injiniya waɗanda ba a kama su ta hanyar ma'aunin folate na yau da kullun ba, wanda zai iya buɗe sabbin fahimta game da yanayi tun daga rashin haihuwa zuwa matsalolin ci gaban jijiyoyi.

A ƙarshe, labaran da aka samu daga watan Janairun 2026 sun nuna hoton wani yanki da ya girma. Binciken da aka yi akai-akai yana ƙara zama mai sauƙi da daidaito tare da raguwar gwajin RBC da kuma fifita gwaje-gwajen jini. Sabbin bincike sun ci gaba da tabbatar da muhimmancin folate ga sakamakon ciki mai lafiya. Abin sha'awa, fannin yana faɗaɗa zuwa gwaje-gwaje na musamman waɗanda za su iya magance matsalar rashin lafiyar folate a matakin ƙwayoyin halitta, wanda ke ba da sabon bege ga marasa lafiya waɗanda suka faɗi cikin mawuyacin hali na gwaji na gargajiya.